During the past decade, Gynaekologisch-Onkologische Schwerpunktpraxis Prof. Dr. med. Lueck, Dr. Schrader und Dr. Noeding conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 11 clinical trials were completed, i.e. on average, 110% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gynaekologisch-Onkologische Schwerpunktpraxis Prof. Dr. med. Lueck, Dr. Schrader und Dr. Noeding" #1 sponsor was "Hoffmann-La Roche" with 11 trials, followed by "Fondazione Michelangelo" with 3 trials sponsored, "AGO Research GmbH" with 1 trials sponsored, "AGO Study Group" with 1 trials sponsored and "Arcagy Research" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gynaekologisch-Onkologische Schwerpunktpraxis Prof. Dr. med. Lueck, Dr. Schrader und Dr. Noeding" #1 collaborator was "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 2 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "German Breast Group" with 2 trials as a collaborator and "Hoffmann-La Roche" with 2 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Gynaekologisch-Onkologische Schwerpunktpraxis Prof. Dr. med. Lueck, Dr. Schrader und Dr. Noeding" are "Breast Cancer" (7 trials), "Breast Neoplasms" (3 trials), "Metastatic Breast Cancer" (3 trials), "Ovarian Cancer" (3 trials) and "Carcinosarcoma" (1 trials). Many other conditions were trialed in "Gynaekologisch-Onkologische Schwerpunktpraxis Prof. Dr. med. Lueck, Dr. Schrader und Dr. Noeding" in a lesser frequency.

Most popular intervention types in "Gynaekologisch-Onkologische Schwerpunktpraxis Prof. Dr. med. Lueck, Dr. Schrader und Dr. Noeding" are "Drug" (21 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (6 trials), "Carboplatin" (5 trials), "Cyclophosphamide" (5 trials), "Pertuzumab" (5 trials) and "Docetaxel" (4 trials). Other intervention names were less common.

The vast majority of trials in "Gynaekologisch-Onkologische Schwerpunktpraxis Prof. Dr. med. Lueck, Dr. Schrader und Dr. Noeding" are 12 trials for "Female" genders and 10 trials for "All" genders.

Currently, there are NaN active trials in "Gynaekologisch-Onkologische Schwerpunktpraxis Prof. Dr. med. Lueck, Dr. Schrader und Dr. Noeding". undefined are not yet recruiting, 2 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Gynaekologisch-Onkologische Schwerpunktpraxis Prof. Dr. med. Lueck, Dr. Schrader und Dr. Noeding, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Gynaekologisch-Onkologische Schwerpunktpraxis Prof. Dr. med. Lueck, Dr. Schrader und Dr. Noeding, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".